Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial

• Główni autorzy: Álvaro Avezum (Autor), Gustavo B F Oliveira (Autor), Haliton Oliveira (Autor), Rosa C Lucchetta (Autor), Valéria F A Pereira (Autor), André L Dabarian (Autor), Ricardo D´O Vieira (Autor), Daniel V Silva (Autor), Adrian P M Kormann (Autor), Alexandre P Tognon (Autor), Ricardo De Gasperi (Autor), Mauro E Hernandes (Autor), Audes D M Feitosa (Autor), Agnaldo Piscopo (Autor), André S Souza (Autor), Carlos H Miguel (Autor), Vinicius O Nogueira (Autor), César Minelli (Autor), Carlos C Magalhães (Autor), Karen M L Morejon (Autor), Letícia S Bicudo (Autor), Germano E C Souza (Autor), Marco A M Gomes (Autor), José J F Raposo Fo (Autor), Alexandre V Schwarzbold (Autor), Alexandre Zilli (Autor), Roberto B Amazonas (Autor), Frederico R Moreira (Autor), Lucas B O Alves (Autor), Silvia R L Assis (Autor), Precil D M M Neves (Autor), Jessica Y Matuoka (Autor), Icaro Boszczowski (Autor), Daniela G M Catarino (Autor), Viviane C Veiga (Autor), Luciano C P Azevedo (Autor), Regis G Rosa (Autor), Renato D Lopes (Autor), Alexandre B Cavalcanti (Autor), Otavio Berwanger (Autor)
• Format: Książka
• Wydane: Elsevier, 2022-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Summary: Background: Previous Randomised controlled trials (RCT) evaluating chloroquine and hydroxychloroquine in non-hospitalised COVID-19 patients have found no significant difference in hospitalisation rates. However, low statistical power precluded definitive answers. Methods: We conducted a mul...